4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001628280-23-032707
Chief Executive Officer sold 57,755 shares at an average $28.12 ($1,624,223)
- Chief Executive Officer acquired 57,755 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Anzalone Christopher Richard Chief Executive Officer | 2023-09-18 | Option exercise | +57,755 | $4.75 | $274,336 | 3,819,093 | D |
| Anzalone Christopher Richard Chief Executive Officer | 2023-09-18 | Sale | −31,523 | $28.00 | $882,644 | 3,787,570 | D |
| Anzalone Christopher Richard Chief Executive Officer | 2023-09-18 | Sale | −26,232 | $28.27 | $741,579 | 3,761,338 | D |
| Derivatives | |||||||
| Anzalone Christopher Richard Chief Executive Officer | 2023-09-18 | Option exercise · Stock Option (right to buy) | +57,555 | 409,225 | D | ||
| Open-market sales · 57,755 sh · avg $28.12 · $1,624,223 | |||||||
Loading xslF345X05/wf-form4_169524780099268.xml…